These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 24364934)
1. Optimizing SLN and NLC by 2(2) full factorial design: effect of homogenization technique. Severino P; Santana MH; Souto EB Mater Sci Eng C Mater Biol Appl; 2012 Aug; 32(6):1375-9. PubMed ID: 24364934 [TBL] [Abstract][Full Text] [Related]
4. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery. Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662 [TBL] [Abstract][Full Text] [Related]
5. Optimization of linalool-loaded solid lipid nanoparticles using experimental factorial design and long-term stability studies with a new centrifugal sedimentation method. Pereira I; Zielińska A; Ferreira NR; Silva AM; Souto EB Int J Pharm; 2018 Oct; 549(1-2):261-270. PubMed ID: 30075252 [TBL] [Abstract][Full Text] [Related]
6. Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake. Tiwari R; Pathak K Int J Pharm; 2011 Aug; 415(1-2):232-43. PubMed ID: 21640809 [TBL] [Abstract][Full Text] [Related]
7. Optimization of high pressure homogenization conditions to produce nanostructured lipid carriers using natural and synthetic emulsifiers. Luisa Lüdtke F; Aparecida Stahl M; Grimaldi R; Bruno Soares Forte M; Lúcia Gigante M; Paula Badan Ribeiro A Food Res Int; 2022 Oct; 160():111746. PubMed ID: 36076468 [TBL] [Abstract][Full Text] [Related]
8. Solid lipid nanoparticles optimized by 2 Rigon RB; Gonçalez ML; Severino P; Alves DA; Santana MHA; Souto EB; Chorilli M Colloids Surf B Biointerfaces; 2018 Nov; 171():501-505. PubMed ID: 30081382 [TBL] [Abstract][Full Text] [Related]
9. Lipid nanoparticles as carrier for octyl-methoxycinnamate: in vitro percutaneous absorption and photostability studies. Puglia C; Bonina F; Rizza L; Blasi P; Schoubben A; Perrotta R; Tarico MS; Damiani E J Pharm Sci; 2012 Jan; 101(1):301-11. PubMed ID: 21905033 [TBL] [Abstract][Full Text] [Related]
10. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation. Khan S; Baboota S; Ali J; Narang RS; Narang JK Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780 [TBL] [Abstract][Full Text] [Related]
11. Modification of oral absorption of oxyresveratrol using lipid based nanoparticles. Sangsen Y; Wiwattanawongsa K; Likhitwitayawuid K; Sritularak B; Wiwattanapatapee R Colloids Surf B Biointerfaces; 2015 Jul; 131():182-90. PubMed ID: 25988282 [TBL] [Abstract][Full Text] [Related]
12. Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy. Saupe A; Gordon KC; Rades T Int J Pharm; 2006 May; 314(1):56-62. PubMed ID: 16574354 [TBL] [Abstract][Full Text] [Related]
13. A novel method to produce solid lipid nanoparticles using n-butanol as an additional co-surfactant according to the o/w microemulsion quenching technique. Mojahedian MM; Daneshamouz S; Samani SM; Zargaran A Chem Phys Lipids; 2013 Sep; 174():32-8. PubMed ID: 23743405 [TBL] [Abstract][Full Text] [Related]
14. Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology. Zhang W; Li X; Ye T; Chen F; Sun X; Kong J; Yang X; Pan W; Li S Int J Pharm; 2013 Sep; 454(1):354-66. PubMed ID: 23876384 [TBL] [Abstract][Full Text] [Related]
16. Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery. Lakhani P; Patil A; Wu KW; Sweeney C; Tripathi S; Avula B; Taskar P; Khan S; Majumdar S Int J Pharm; 2019 Dec; 572():118771. PubMed ID: 31669555 [TBL] [Abstract][Full Text] [Related]
17. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure. Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990 [TBL] [Abstract][Full Text] [Related]
18. Preparation of Coenzyme Q10 nanostructured lipid carriers for epidermal targeting with high-pressure microfluidics technique. Chen S; Liu W; Wan J; Cheng X; Gu C; Zhou H; Chen S; Zhao X; Tang Y; Yang X Drug Dev Ind Pharm; 2013 Jan; 39(1):20-8. PubMed ID: 23116283 [TBL] [Abstract][Full Text] [Related]
19. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications. Gokce EH; Korkmaz E; Dellera E; Sandri G; Bonferoni MC; Ozer O Int J Nanomedicine; 2012; 7():1841-50. PubMed ID: 22605933 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations. Souto EB; Wissing SA; Barbosa CM; Müller RH Eur J Pharm Biopharm; 2004 Jul; 58(1):83-90. PubMed ID: 15207541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]